Table 1 Characteristic of included studies (n no. of patients)
From: Lactate dehydrogenase elevations is associated with severity of COVID-19: a meta-analysis
Study, year | Country | Females, n (%) | Median age | Total patients | Severe patients, n (%) | LDH (increased/total), n (%) | |
|---|---|---|---|---|---|---|---|
Severe | Non-severe | ||||||
Huang, 2020 | China | 11 (26.8%) | 49.0 | 41 | 13 (31.7%) | 12/13 (92.3%) | 17/27 (63.0%) |
Wang, 2020 | China | 37 (54.0%) | 42.0 | 69 | 14 (20.3%) | 10/12 (83.3%) | 15/49 (30.6%) |
Zhou, 2020 | China | 72 (38.0%) | 56.0 | 191 | 54 (28.3%) | 53/54 (98.1%) | 70/130 (53.8%) |
Zhang, 2020 | China | 66 (57.4%) | 49.5 | 115 | 31 (30.0%) | 17/31 (54.8%) | 9/84 (10.7%) |
Wan, 2020 | China | 63 (46.7%) | 47.0 | 135 | 40 (29.6%) | 30/40 (75.0%) | 28/95 (29.5%) |
Chen, 2020 | China | 4 (19.0%) | 56.0 | 21 | 11 (52.4%) | 10/11 (90.9%) | 1/10 (10.0%) |